Onkologie. 2012:6(5):241-247

Tumor markers in head and neck squamous cell carcinomas

David Kalfeřt1, Marie Ludvíková2,3
1 Klinika otorinolaryngologie a chirurgie hlavy a krku, LF v HK, UK v Praze, FN HK
2 Ústav biologie, Lékařská fakulta v Plzni, UK v Praze
3 Ústav patologie, VFN v Praze

Head and neck squamous cell cancer (HNSCC) is the six most common cancer in the world. In attempts to improve therapy of this cancer,

contemporary research is focused predominantly on new tumor markers and evaluation of their diagnostic, prognostic and predictive

significance for routine clinical practice. Molecular tumor markers at the same time very well reflect pathobiological processes in tumors.

New etiological and pathobiological aspects of cancerogenesis of HNSCC were lately introduced. Namely epigenetic mechanisms, RNA

interference and microRNA, cancer stem cells and epithelial-mesenchymal transition play important role in cancerogenesis as well as

represent new source of molecular tumor markers and potential target of biological therapy.

Keywords: molecular tumor markers, epigenetics, RNA interference, cancer stem cells, target therapy

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kalfeřt D, Ludvíková M. Tumor markers in head and neck squamous cell carcinomas. Onkologie. 2012;6(5):241-247.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ludvíková M, Pešta M, Holubec L, Jr., Kalfeřt D. Nové aspekty patobiologie nádorů. Čes-slov Patol 2009; 4(4): 94-99.
    2. Ernoux-Neufcoeur P, Arafa M, Decaestecker C, Duray A, Remmelink M, Leroy X, et al. Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. J Cancer Res Clin Oncol. 2011; 137(1): 173-181. Go to original source... Go to PubMed...
    3. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11(1): 9-22. Go to original source... Go to PubMed...
    4. Peltonen JK, Helppi HM, Paakko P, Turpeenniemi-Hujanen T, Vahakangas KH. p53 in head and neck cancer: functional consequences and environmental implications of TP53 mutations. Head Neck Oncol 2010; 2: 36. Go to original source... Go to PubMed...
    5. Torrente MC, Rodrigo JP, Haigentz M, Jr., Dikkers FG, Rinaldo A, Takes RP, et al. Human papillomavirus infections in laryngeal cancer. Head Neck 2011; 33(4): 581-586. Go to original source... Go to PubMed...
    6. Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. Human Papillomavirus in Non-Oropharyngeal Head and Neck Cancers: A Systematic Literature Review. Head Neck Pathol 2012; 6(Suppl. 1): 104-120. Go to original source... Go to PubMed...
    7. zur Hausen H. Roots and perspectives of contemporary papillomavirus research. J Cancer Res Clin Oncol 1996; 122(1): 3-13. Go to original source... Go to PubMed...
    8. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2(5): 342-350. Go to original source... Go to PubMed...
    9. Duenas-Gonzalez A, Lizano M, Candelaria M, Cetina L, Arce C, Cervera E. Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer 2005; 4: 38. Go to original source... Go to PubMed...
    10. Lehoux M, D'Abramo CM, Archambault J. Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics 2009; 12(5-6): 268-280. Go to original source... Go to PubMed...
    11. McCance DJ. Human papillomaviruses and cell signaling. Sci STKE 2005; 2005(288): 29. Go to original source... Go to PubMed...
    12. Psyrri A, DiMaio D. Human papillomavirus in cervical and head-and-neck cancer. Nat Clin Pract Oncol. 2008; 5(1): 24-31. Go to original source... Go to PubMed...
    13. Laco J, Slaninka I, Jirasek M, Celakovsky P, Vosmikova H, Ryska A. High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions. Pathol Res Pract 2008; 204(8): 545-552. Go to original source... Go to PubMed...
    14. Baumann JL, Cohen S, Evjen AN, Law JH, Vadivelu S, Attia A, et al. Human papillomavirus in early laryngeal carcinoma. Laryngoscope 2009; 119(8): 1531-1537. Go to original source... Go to PubMed...
    15. Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol 2006; 24(25): 4170-4176. Go to original source... Go to PubMed...
    16. Allen CT, Lewis JS, Jr., El-Mofty SK, Haughey BH, Nussenbaum B. Human papillomavirus and oropharynx cancer: biology, detection and clinical implications. Laryngoscope 2010; 120(9): 1756-1772. Go to original source... Go to PubMed...
    17. Friedmann DR, Lalwani AK. Genetic basis of conditions commonly seen in ORL practice. Adv Otorhinolaryngol 2011; 70: 1-9. Go to original source... Go to PubMed...
    18. Gronbaek K, Hother C, Jones PA. Epigenetic changes in cancer. Apmis 2007; 115(10): 1039-1059. Go to original source... Go to PubMed...
    19. Shelton BP, Misso NL, Shaw OM, Arthaningtyas E, Bhoola KD. Epigenetic regulation of human epithelial cell cancers. Curr Opin Mol Ther 2008; 10(6): 568-578.
    20. Glazer CA, Chang SS, Ha PK, Califano JA. Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice. Oral Oncol 2009; 45(4-5): 440-446. Go to original source... Go to PubMed...
    21. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002; 196(1): 1-7. Go to original source... Go to PubMed...
    22. Schmezer P, Plass C. Epigenetic aspects in carcinomas of the head and neck. Hno 2008; 56(6): 594-602. Go to original source... Go to PubMed...
    23. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391(6669): 806-811. Go to original source... Go to PubMed...
    24. Kontrová K, Škop V, Sajdok J, Zídková J. RNA interference a praktické aspekty jejího využití. Chemické Listy 2009; 103(4): 302-309.
    25. Bhindi R, Fahmy RG, Lowe HC, Chesterman CN, Dass CR, Cairns MJ, et al. Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies. Am J Pathol 2007; 171(4): 1079-1088. Go to original source... Go to PubMed...
    26. Wu W, Sun M, Zou GM, Chen J. MicroRNA and cancer: Current status and prospective. Int J Cancer. 2007; 120(5): 953-960. Go to original source... Go to PubMed...
    27. Hagan JP, Croce CM. MicroRNAs in carcinogenesis. Cytogenet Genome Res 2007; 118(2-4): 252-259. Go to original source... Go to PubMed...
    28. Avissar M, Christensen BC, Kelsey KT, Marsit CJ. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009; 15(8): 2850-2855. Go to original source... Go to PubMed...
    29. Papagiannakopoulos T, Kosik KS. MicroRNAs: regulators of oncogenesis and stemness. BMC Med 2008; 6: 15. Go to original source... Go to PubMed...
    30. Chen LH, Tsai KL, Chen YW, Yu CC, Chang KW, Chiou SH, et al. MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma. J Oncol 2010; 135632. Go to original source... Go to PubMed...
    31. Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 2010; 23(6): 1625-1633. Go to original source... Go to PubMed...
    32. Ghosal A, Kabir AH, Mandal A. RNA interference and its therapeutic potential. Central European Journal of Medicine 2011; 6(2): 137-147. Go to original source...
    33. Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science 1977; 197(4302): 461-463. Go to original source... Go to PubMed...
    34. Gil J, Stembalska A, Pesz KA, Sasiadek MM. Cancer stem cells: the theory and perspectives in cancer therapy. J Appl Genet 2008; 49(2): 193-199. Go to original source... Go to PubMed...
    35. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 2006; 66(4): 1883-1890; discussion 95-96. Go to original source... Go to PubMed...
    36. Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol. 2007; 23: 675-699. Go to original source... Go to PubMed...
    37. Wang JC, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005; 15(9): 494-501. Go to original source... Go to PubMed...
    38. McDonald SA, Graham TA, Schier S, Wright NA, Alison MR. Stem cells and solid cancers. Virchows Arch 2009; 455(1): 1-13. Go to original source... Go to PubMed...
    39. Sayed SI, Dwivedi RC, Katna R, Garg A, Pathak KA, Nutting CM, et al. Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral Oncol 2011; 47(4): 237-243. Go to original source... Go to PubMed...
    40. Martinez-Climent JA, Andreu EJ, Prosper F. Somatic stem cells and the origin of cancer. Clin Transl Oncol 2006; 8(9): 647-663. Go to original source... Go to PubMed...
    41. Croker AK, Allan AL. Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med 2008; 12(2): 374-390. Go to original source... Go to PubMed...
    42. Dick JE. Stem cell concepts renew cancer research. Blood 2008; 112(13): 4793-4807. Go to original source... Go to PubMed...
    43. Bapat SA. Evolution of cancer stem cells. Semin Cancer Biol 2007; 17(3): 204-213. Go to original source... Go to PubMed...
    44. Li F, Tiede B, Massague J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 2007; 17(1): 3-14. Go to original source... Go to PubMed...
    45. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006; 355(12): 1253-1261. Go to original source... Go to PubMed...
    46. Mizrak D, Brittan M, Alison MR. CD133: molecule of the moment. J Pathol 2008; 214(1): 3-9. Go to original source... Go to PubMed...
    47. Albers AE, Chen C, Koberle B, Qian X, Klussmann JP, Wollenberg B, et al. Stem cells in squamous head and neck cancer. Crit Rev Oncol Hematol 2012; 81(3): 224-240. Go to original source... Go to PubMed...
    48. Pries R, Witrkopf N, Trenkle T, Nitsch SM, Wollenberg B. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In Vivo 2008; 22(1): 89-92. Go to PubMed...
    49. Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 2009; 385(3): 307-313. Go to original source... Go to PubMed...
    50. Monroe MM, Anderson EC, Clayburgh DR, Wong MH. Cancer stem cells in head and neck squamous cell carcinoma. J Oncol 2011; 2011: 762-780. Go to original source... Go to PubMed...
    51. Wu Y, Zhou BP. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai) 2008; 40(7): 643-650. Go to original source... Go to PubMed...
    52. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007; 213(2): 374-383. Go to original source... Go to PubMed...
    53. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007; 39(3): 305-318. Go to original source... Go to PubMed...
    54. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133(4): 704-715. Go to original source... Go to PubMed...
    55. Fischer CA, Kampmann M, Zlobec I, Green E, Tornillo L, Lugli A, et al. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 2010; 21(10): 1961-1966. Go to original source... Go to PubMed...
    56. Takes RP, Rinaldo A, Silver CE, Piccirillo JF, Haigentz M, Jr., Suarez C, et al. Future of the TNM classification and staging system in head and neck cancer. Head Neck 2010; 32(12): 1693-1711. Go to original source... Go to PubMed...
    57. Schaaij-Visser TB, Brakenhoff RH, Leemans CR, Heck AJ, Slijper M. Protein biomarker discovery for head and neck cancer. J Proteomics 2010; 73(10): 1790-1803. Go to original source... Go to PubMed...
    58. El-Naggar AK. Pathobiology of head and neck squamous tumorigenesis. Curr Cancer Drug Targets 2007; 7(7): 606-612. Go to original source... Go to PubMed...
    59. Lee KD, Lee HS, Jeon CH. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas. Anticancer Res 2011; 31(4): 1161-1167.
    60. Demiroz C, Eisbruch A. Individualizing therapy for oropharyngeal cancer patients. Expert Rev Anticancer Ther 2009; 9(9): 1181-1184. Go to original source... Go to PubMed...
    61. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100(1): 57-70. Go to original source... Go to PubMed...
    62. Grimminger CM, Danenberg PV. Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review. Eur Arch Otorhinolaryngol 2011; 268(1): 5-16. Go to original source... Go to PubMed...
    63. Reimers N, Kasper HU, Weissenborn SJ, Stutzer H, Preuss SF, Hoffmann TK, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120(8): 1731-1738. Go to original source... Go to PubMed...
    64. Lewis JS, Jr., Thorstad WL, Chernock RD, Haughey BH, Yip JH, Zhang Q, et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 2010; 34(8): 1088-1096. Go to original source... Go to PubMed...
    65. Mendelsohn AH, Lai CK, Shintaku IP, Elashoff DA, Dubinett SM, Abemayor E, et al. Histopathologic findings of HPV and p16 positive HNSCC. Laryngoscope 2010; 120(9): 1788-1794. Go to original source... Go to PubMed...
    66. Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, et al. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Head Neck 2009; 31(8): 1039-1048. Go to original source... Go to PubMed...
    67. Sappayatosok K, Maneerat Y, Swasdison S, Viriyavejakul P, Dhanuthai K, Zwang J, et al. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation. Med Oral Patol Oral Cir Bucal 2009; 14(7): E319-324. Go to PubMed...
    68. Tanigaki Y, Nagashima Y, Kitamura Y, Matsuda H, Mikami Y, Tsukuda M. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma. Int J Mol Med 2004; 14(3): 389-395. Go to original source...
    69. Brocic M, Kozomara R, Cerovic S, Jovic N, Vukelic-Markovic S, Stosic S. Clinical significance of vascular endothelial growth factor expression in patients with carcinoma of the mouth floor and tongue. Vojnosanit Pregl 2009; 66(6): 440-448. Go to original source... Go to PubMed...
    70. Fei J, Hong A, Dobbins TA, Jones D, Lee CS, Loo C, et al. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor. Ann Surg Oncol 2009; 16(10): 2908-2917. Go to original source... Go to PubMed...
    71. Diniz-Freitas M, Garcia-Caballero T, Antunez-Lopez J, Gandara-Rey JM, Garcia-Garcia A. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 2006; 42(2): 190-200. Go to original source... Go to PubMed...
    72. Kaur G, Carnelio S, Rao N, Rao L. Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: an immunohistochemical study. Indian J Dent Res 2009; 20(1): 71-76. Go to original source... Go to PubMed...
    73. Mahomed F, Altini M, Meer S. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis. Oral Dis 2007; 13(4): 386-392. Go to original source... Go to PubMed...
    74. Ren J, Zhu D, Liu M, Sun Y, Tian L. Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. Eur J Cancer 2010; 46(18): 3409-3416. Go to original source... Go to PubMed...
    75. Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, et al. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 2007; 67(23): 11111-11116. Go to original source... Go to PubMed...
    76. Long XB, Sun GB, Hu S, Liang GT, Wang N, Zhang XH, et al. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncol Rep 2009; 22(5): 1189-1195. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.